
China Lianyungang Jinkang Hexin Pharmaceutical Co Ltd. specialiter in L-5-Methyltetrahydrofolata ab 2007.
Anno 2012, Jinkang Pharmaceuticae mundi purissimae et firmissimae L-5-Methyltetrahydrofolatae Calcium Crystallinum patente productum elaboraverunt, trademark Magnafolate®, US Patent 9,150,982 B2, Patent Unionis Europaeae No. EP2805952B1, quod in Canada, Australia producitur. ac eleifend.
Ex MMXII ad 2016, Goldcom Hutchinsonus patentes magnafolatas per orbem terrarum applicavit et descripserunt. Nunc Jinkang Hesin maximas patentes Calcii coetus L-5-Methyltetrahydrofolatae in mundo possidet.
Nunc JKHX factus est 1 effector Calcii L-5-Methyltetrahydrofolati in Sinis, et plus usus est in educendo in Americam Septentrionalem, Europam, Brasiliam et alia loca.
L-5-Methyltetrahydrofolatum Calcium Ingredient Utilitas:
US FDA NDI 920 registration
Gras auto-affirmavit
Patented C-Crystallinus Calcium Salt
Summum gradum L-5-methyltetrahydrofolatum (>85)
Stabilis ad cella temperies pro 3 annis, etiam in zona IVB .
Kosher, Halal, ISO22000.
Licentia Ciborum Fabricatio, etc.
In conclusione, Calcium L-5-Methyltetrahydrofolatum magnum est supplementum nutritionis et medicamentum pharmaceuticum, et magni momenti est eligere certum supplementum.

Magnafolate® calcii L-5-methyltetrahydrofolati tutior, purior, stabilior et aptus est amplis hominibus in iis cum mutationum generum MTHFR. Calcium L-5-methyltetrahydrofolatum non indiget metabolisi in corpore et immediate absorberi potest.